As identified, we could not experimentally validate all predicted targets related to thrombosis (e.g., TRPC6) or viral infection/reactivation (e.g., deoxycytidine kinase [DCK; EC number 2.7.1.74], Thymidine kinase [HSV; EC number 2.7.1.21], Exportin-1 [XPO1], or Ubiquitin-conjugating enzyme E2 N [Ube2N; EC number 2.3.2.23]). Here, DCK is linked to viral infectious disease.